Business Development leadership team

The partners who build teams

Our Business Development team is structured by therapeutic area to ensure we have the right expertise to identify, evaluate and transact on the right opportunities. Our Business Development leaders bring deep science, development and business expertise and work closely with R&D and commercial leaders to source external innovation that will augment our internal pipeline. 

"We are open to a wide range of partnership opportunities focused on transformational science and we are committed to being a leading biopharma partner."


Elizabeth Mily, Executive Vice President Strategy and Business Development

Cardiovascular, Fibrosis, Immunology and Neuroscience

Janette Dean
Vice President, Transactional Excellence and Interim Head of Cardiovascular, Fibrosis, Immunology, Neuroscience Business Development
Chester, UK
Anna Rivkin, Ph.D.
Executive Director, Business Development, Cardiovascular, Fibrosis, Immunology, Neuroscience, Japan Search & Evaluation
Lawrenceville, NJ
Dan Ring
Executive Director, Business Development, Cardiovascular, Fibrosis, Immunology, Neuroscience Transactions
Lawrenceville, NJ
Yoshitake Maeda
Director, Search & Evaluation, Japan & Asia, Business Development
Toyko, Japan

Corporate Development

Brian Heaphy
Vice President, Corporate Development
Lawrenceville, NJ
Erica Horwitz
Vice President, Head of M&A
Lawrenceville, NJ
Robert Merriman
Executive Director, Corporate Development Transactions
Lawrenceville, NJ
Daniel O'Connell
Executive Director, Equity and Venture Capital
Lawrenceville, NJ
Sunil Patel
Senior Director, Divestitures
Lawrenceville, NJ

Hematology, Cell Therapy & China

Jie D'Elia
Vice President, Business Development, Hematology, Cell Therapy and China
Lawrenceville, NJ
Stephen O'Keefe
Executive Director, Head of Hematology and Summit
Summit, NJ
Jennifer Schwartz
Executive Director, Business Development, Hematology & Cell Therapy Transactions
Lawrenceville, NJ
Fang Zhang
Executive Director, China Business Development

Innovative Technologies 

Konstantina Katcheves
Vice President, Innovative Technologies Business Development
Lawrenceville, NJ
Michael Cucolo
Executive Director, Business Development, Research Enabling Transactions
Lawrenceville, NJ
Jay Foust
Executive Director, Business Development, Translational Medicine
Lawrenceville, NJ
Michael McInerney
Senior Director, Business Development, Digital Health
Lawrenceville, NJ


Janusz Kostanski, Ph.D.
Vice President, Oncology Business Development
Lawrenceville, NJ
Martin Crook
Executive Director, Business Development, Oncology Search & Evaluation
Lawrenceville, NJ
Brian Cook
Executive Director, Business Development, Oncology Transactions
Lawrenceville, NJ

Interested in working with us? 

Begin a discussion >